A detailed history of Legal & General Group PLC transactions in Geron Corp stock. As of the latest transaction made, Legal & General Group PLC holds 441,065 shares of GERN stock, worth $2.02 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
441,065
Previous 396,052 11.37%
Holding current value
$2.02 Million
Previous $1.31 Million 43.19%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$3.1 - $5.09 $139,540 - $229,116
45,013 Added 11.37%
441,065 $1.87 Million
Q1 2024

May 14, 2024

SELL
$1.75 - $3.44 $25,147 - $49,432
-14,370 Reduced 3.5%
396,052 $1.31 Million
Q4 2023

Feb 15, 2024

BUY
$1.74 - $2.31 $553 - $734
318 Added 0.08%
410,422 $865,000
Q3 2023

Nov 14, 2023

BUY
$2.11 - $3.28 $15,464 - $24,039
7,329 Added 1.82%
410,104 $869,000
Q2 2023

Aug 14, 2023

BUY
$1.97 - $3.69 $448,027 - $839,198
227,425 Added 129.7%
402,775 $1.29 Million
Q1 2023

May 15, 2023

BUY
$2.14 - $3.4 $60,285 - $95,781
28,171 Added 19.14%
175,350 $380,000
Q4 2022

Feb 14, 2023

BUY
$2.03 - $2.42 $10,795 - $12,869
5,318 Added 3.75%
147,179 $356,000
Q3 2022

Nov 14, 2022

BUY
$1.67 - $2.94 $7,748 - $13,641
4,640 Added 3.38%
141,861 $332,000
Q2 2022

Aug 22, 2022

BUY
$1.19 - $1.65 $37,592 - $52,123
31,590 Added 29.91%
137,221 $213,000
Q3 2021

Nov 15, 2021

BUY
$1.2 - $1.5 $56,658 - $70,822
47,215 Added 80.83%
105,631 $144,000
Q2 2021

Aug 12, 2021

SELL
$1.25 - $1.83 $5,143 - $7,530
-4,115 Reduced 6.58%
58,416 $83,000
Q1 2021

May 17, 2021

BUY
$1.52 - $2.1 $6,254 - $8,641
4,115 Added 7.04%
62,531 $100,000
Q3 2020

Nov 13, 2020

BUY
$1.59 - $2.19 $23,288 - $32,076
14,647 Added 33.46%
58,416 $102,000
Q1 2020

May 14, 2020

SELL
$0.89 - $1.49 $5,429 - $9,090
-6,101 Reduced 12.23%
43,769 $52,000
Q3 2019

Nov 13, 2019

BUY
$1.15 - $1.59 $18,103 - $25,029
15,742 Added 46.13%
49,870 $67,000
Q1 2019

May 15, 2019

BUY
$1.01 - $1.83 $5,246 - $9,506
5,195 Added 17.96%
34,128 $57,000
Q3 2018

Nov 20, 2018

BUY
$1.76 - $6.38 $9,037 - $32,761
5,135 Added 21.58%
28,933 $50,000
Q2 2018

Aug 10, 2018

SELL
$3.29 - $4.82 $3,546 - $5,195
-1,078 Reduced 4.33%
23,798 $82,000
Q1 2018

May 17, 2018

SELL
$1.81 - $5.98 $22,896 - $75,647
-12,650 Reduced 33.71%
24,876 $106,000
Q4 2017

Feb 13, 2018

BUY
$1.8 - $2.32 $67,546 - $87,060
37,526
37,526 $68,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.73B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.